Guizhou Yibai Pharmaceutical Co Ltd Financial Flexibility Index
Guizhou Yibai Pharmaceutical Co Ltd financial flexibility index. Guizhou Yibai Pharmaceutical Co Ltd (600594) has a Financial Flexibility Index of 0.03x as of September 2025. Free cash flow of CN¥40.36 Million (operating CF CN¥33.28 Million minus capex CN¥7.08 Million) represents 0% of total liabilities (CN¥1.32 Billion). See 600594 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Guizhou Yibai Pharmaceutical Co Ltd (2002–2025)
Financial flexibility index of Guizhou Yibai Pharmaceutical Co Ltd from 2002 to 2025. Historical Financial Flexibility Index trend for Guizhou Yibai Pharmaceutical Co Ltd across 24 annual periods. Check Guizhou Yibai Pharmaceutical Co Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Guizhou Yibai Pharmaceutical Co Ltd Financial Flexibility Index by Year (2002–2025)
Guizhou Yibai Pharmaceutical Co Ltd financial flexibility index by year from 2002 to 2025. Year-by-year free cash flow to debt coverage for Guizhou Yibai Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Guizhou Yibai Pharmaceutical Co Ltd cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.25x | CN¥291.70 Million | CN¥256.71 Million | CN¥1.17 Billion | ▲ +103.1% |
| 2024 | 0.12x | CN¥183.19 Million | CN¥86.87 Million | CN¥1.49 Billion | ▼ -61.9% |
| 2023 | 0.32x | CN¥507.99 Million | CN¥377.61 Million | CN¥1.58 Billion | ▼ -19.3% |
| 2022 | 0.40x | CN¥668.22 Million | CN¥345.30 Million | CN¥1.68 Billion | ▼ -56.6% |
| 2021 | 0.92x | CN¥1.38 Billion | CN¥934.21 Million | CN¥1.51 Billion | ▲ +112.3% |
| 2020 | 0.43x | CN¥762.40 Million | CN¥366.66 Million | CN¥1.76 Billion | ▲ +45.3% |
| 2019 | 0.30x | CN¥563.99 Million | CN¥362.71 Million | CN¥1.89 Billion | ▲ +42.5% |
| 2018 | 0.21x | CN¥535.62 Million | CN¥214.30 Million | CN¥2.56 Billion | ▼ -50.8% |
| 2017 | 0.42x | CN¥1.08 Billion | CN¥681.78 Million | CN¥2.55 Billion | ▲ +42.7% |
| 2016 | 0.30x | CN¥713.15 Million | CN¥380.62 Million | CN¥2.40 Billion | ▼ -29.6% |
| 2015 | 0.42x | CN¥861.70 Million | CN¥573.68 Million | CN¥2.04 Billion | ▲ +17.5% |
| 2014 | 0.36x | CN¥745.52 Million | CN¥541.58 Million | CN¥2.07 Billion | ▼ -46.3% |
| 2013 | 0.67x | CN¥850.72 Million | CN¥577.24 Million | CN¥1.27 Billion | ▼ -1.4% |
| 2012 | 0.68x | CN¥497.66 Million | CN¥288.01 Million | CN¥731.33 Million | ▲ +7.8% |
| 2011 | 0.63x | CN¥420.17 Million | CN¥277.83 Million | CN¥665.51 Million | ▲ +163.1% |
| 2010 | 0.24x | CN¥165.32 Million | CN¥115.66 Million | CN¥688.82 Million | ▼ -7.7% |
| 2009 | 0.26x | CN¥148.51 Million | CN¥103.88 Million | CN¥571.26 Million | ▼ -36.0% |
| 2008 | 0.41x | CN¥252.12 Million | CN¥189.26 Million | CN¥620.62 Million | ▲ +386.9% |
| 2007 | 0.08x | CN¥50.92 Million | CN¥11.94 Million | CN¥610.24 Million | ▼ -58.4% |
| 2006 | 0.20x | CN¥112.78 Million | CN¥95.77 Million | CN¥562.27 Million | ▲ +33.1% |
| 2005 | 0.15x | CN¥98.37 Million | CN¥17.38 Million | CN¥652.65 Million | ▼ -15.7% |
| 2004 | 0.18x | CN¥64.60 Million | CN¥-44.80 Million | CN¥361.10 Million | ▼ -81.2% |
| 2003 | 0.95x | CN¥261.57 Million | CN¥92.10 Million | CN¥274.93 Million | ▲ +73.4% |
| 2002 | 0.55x | CN¥95.96 Million | CN¥73.46 Million | CN¥174.87 Million | — |